irinotecan,gimeracil,tegafur,nivolumab,capecitabine,oxaliplatin,oteracil,oxaliplatin,5-fluorouracil
otsuka,bms,nordic group,ono pharma
['nivolumab', 'nivo', 'norpact,1', 'norpact-1', 'attraction-5']
2 bad news this morning at #asco2023: attraction-5 (ph iii): adjuvant nivolumab + ct for stage iii gc/gej norpact-1 (ph ii): 4 cycles neoadjuvant folfirinox in resectable pdac - shorter os in the neoadjuvant arm
Young Oncologist👩🏼‍⚕️learning about #GastricCancer #PancreaticCancer and #PrecisionOncology 🧬 at the Catalan Institute of Oncology📍 Always near the 🌊